Cargando…
IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers
IQOS, the leading heated tobacco product globally, recently received ‘reduced exposure’ authorization from the US Food and Drug Administration. Independent research focusing on IQOS marketing and potential impact on consumers’ perceptions and behavior, and ultimately public health, is critical. The...
Autores principales: | Berg, Carla J., Abroms, Lorien C., Levine, Hagai, Romm, Katelyn F., Khayat, Amal, Wysota, Christina N., Duan, Zongshuan, Bar-Zeev, Yael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508084/ https://www.ncbi.nlm.nih.gov/pubmed/34639851 http://dx.doi.org/10.3390/ijerph181910551 |
Ejemplares similares
-
Anticipating IQOS market expansion in the United States
por: Abroms, Lorien, et al.
Publicado: (2022) -
IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel
por: Levine, Hagai, et al.
Publicado: (2023) -
Impact of different health warning label and reduced exposure messages in IQOS ads on perceptions among US and Israeli adults
por: Berg, Carla J., et al.
Publicado: (2023) -
IQOS point-of-sale marketing strategies in Israel: a pilot study
por: Bar-Zeev, Yael, et al.
Publicado: (2019) -
Theory-based correlates of cannabis use and intentions among US and Israeli adults: a mixed methods study
por: Cui, Yuxian, et al.
Publicado: (2023)